alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › reveals

reveals

5 studies tagged reveals, dated 2013-02-01 to 2024-06-18. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Plasma pTau181 Reveals a Pathological Signature that Predicts Cognitive Outcomes in Lewy Body Disease 2024-06-18
  2. Personalized whole-brain neural mass models reveal combined Aβ and tau hyperexcitable influences in Alzheimer's disease 2024-05-04
  3. Profiling of Serum Exosome MiRNA Reveals the Potential of a MiRNA Panel as Diagnostic Biomarker for Alzheimer's Disease 2021-02-24

Studies

5 studies carry this tag.

Date range

2013 to 2024

Top journals

  • Annals of neurology 1
  • Biophysical journal 1
  • Communications biology 1
  • Molecular neurobiology 1
  • Progress in neurobiology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Plasma pTau181 Reveals a Pathological Signature that Predicts Cognitive Outcomes in Lewy Body Disease

    ✓ Peer-reviewed alzhub usefulness score 69 out of 100. Annals of neurology 2024-06-18 Biomarkers

    Our findings suggest that plasma pTau181 is a promising biomarker for concurrent ADNC and amyloidosis in LBD.

  2. Personalized whole-brain neural mass models reveal combined Aβ and tau hyperexcitable influences in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Communications biology 2024-05-04 Biomarkers

    Neuronal dysfunction and cognitive deterioration in Alzheimer's disease (AD) are likely caused by multiple pathophysiological factors.

  3. Profiling of Serum Exosome MiRNA Reveals the Potential of a MiRNA Panel as Diagnostic Biomarker for Alzheimer's Disease

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Molecular neurobiology 2021-02-24 Biomarkers

    Alzheimer's disease (AD) is the most common neurodegenerative disease in the older adults.

  4. Acute phase markers in CSF reveal inflammatory changes in Alzheimer's disease that intersect with pathology, APOE ε4, sex and age

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Progress in neurobiology 2020-08-31 Biomarkers

    It is unknown how neuroinflammation may feature in the etiology of Alzheimer's disease (AD).

  5. Single-molecule imaging reveals aβ42:aβ40 ratio-dependent oligomer growth on neuronal processes

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Biophysical journal 2013-02-01 Biomarkers

    Soluble oligomers of the amyloid-β peptide have been implicated as proximal neurotoxins in Alzheimer's disease.

All topic tags with their study counts